Prime Medicine (PRME) Operating Margin Growth (1y) (2025 - 2026)

Prime Medicine (PRME) Operating Margin Growth (1y) (2025 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Operating Margin Growth (1y) (Qtr)
1 Oculis Holding AG 67,072.09 Bn 67,072.09 Bn - -
2 Nanobiotix 1,894.61 Bn 1,894.55 Bn - -
3 Akari Therapeutics 1,014.18 Bn 1,014.18 Bn - -
4 BeOne Medicines 471.64 Bn 466.85 Bn 1.35 Bn 1,552.00
5 Vertex Pharmaceuticals 121.72 Bn 114.47 Bn 2.59 Bn 1,536.00
6 Regeneron Pharmaceuticals 68.28 Bn 59.52 Bn 3.31 Bn -170.00
7 Belite Bio 61.40 Bn 61.40 Bn - -
8 Argenx Se 56.94 Bn 56.94 Bn 1.18 Bn 1,276.00
9 Revolution Medicines 37.37 Bn 37.37 Bn - -
10 Prime Medicine 524.20 Mn 524.20 Mn - -231,422.00

Historic Data

Download Data
DateValue
Mar 31, 2026 -231,422.00
Dec 31, 2025 -377,473.00
Sep 30, 2025 2.15 Mn
Mar 31, 2025 457,622.00